We used CRISPR-Cas9 gene editing to recapitulate the genetic basis of human frontotemporal dementia in the powerful genetic experimental organism Drosophila by modeling the disease-causing proline 301 to leucine in fly Tau. Here, MAPT is linked to frontotemporal dementia.